Lv5
850 积分 2025-07-04 加入
Investigations to Assess the Impact of Syk-Inhibition on Antibody-Mediated Desialylation: Novel Implications on Therapy for Immune Thrombocytopenia
6天前
已关闭
Fostamatinib for Persistent/Chronic Adult Immune Thrombocytopenia
6天前
已完结
The SYK tyrosine kinase: a crucial player in diverse biological functions
6天前
已完结
Spleen Tyrosine Kinase Inhibition: A New Promising Approach to Chronic and Refractory Immune Thrombocytopenia
22天前
已完结
Spleen Tyrosine Kinase Inhibition: A New Promising Approach to Chronic and Refractory Immune Thrombocytopenia
22天前
已关闭
Spleen Tyrosine Kinase Inhibition: A New Promising Approach to Chronic and Refractory Immune Thrombocytopenia
22天前
已关闭
Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas
27天前
已完结
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial
27天前
已完结
Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
28天前
已完结
Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study
1个月前
已完结
皖公网安备34019202002308
